Nanobiotix: Innovating Treatments and Transparency

Nanobiotix (NBTX) has released an update.

Nanobiotix, a Paris-based biotech company known for its innovative nanotechnology platforms targeting oncology and CNS disorders, has updated its voting rights and share capital information as of June 30, 2024. The company, listed on both Euronext Paris and Nasdaq, emphasizes its commitment to revolutionizing patient treatment outcomes and has a robust intellectual property portfolio with over 25 patent families. Nanobiotix maintains transparency in its operations by adhering to French Commercial Code regulations, ensuring public access to essential company data regarding voting rights and share capital.

For further insights into NBTX stock, check out TipRanks’ Stock Analysis page.